Quantifying the direct public health care cost of systemic sclerosis

September 2, 2020
Morrisroe K, Stevens W, Sahhar J, Ngian G-S, Rabusa C, Ferdowsi N, Hill C, Proudman S, Nikpour M
Abstract
Introduction: Systemic sclerosis (SSc) is a chronic multisystem autoimmune disease characterized by skin and internal organ fibrosis. It is classified into limited (lcSSc) and diffuse cutaneous (dcSSc)disease subtypes based on the extent of skin involvement. Worldwide prevalence of SSc varies from 7/million to 489/million, with the reported prevalence in Australia being one of the highest.

©2020 Australian Scleroderma Interest Group (ASIG), All rights reserved.

©2020 Australian Scleroderma Interest Group (ASIG), All rights reserved.